CytomX Therapeutics, Inc. (CTMX)
2.905
-0.08
(-2.52%)
USD |
NASDAQ |
Jun 10, 16:00
2.895
-0.01
(-0.34%)
After-Hours: 20:00
CytomX Therapeutics Profit Margin (Quarterly) : -177.9% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -177.9% |
| December 31, 2025 | -4.00K% |
| September 30, 2025 | -238.6% |
| June 30, 2025 | -0.83% |
| March 31, 2025 | 46.20% |
| December 31, 2024 | 49.55% |
| September 30, 2024 | 17.16% |
| June 30, 2024 | -26.02% |
| March 31, 2024 | 33.26% |
| December 31, 2023 | 3.15% |
| September 30, 2023 | 11.34% |
| June 30, 2023 | -4.40% |
| March 31, 2023 | -14.09% |
| December 31, 2022 | -43.61% |
| September 30, 2022 | -260.7% |
| June 30, 2022 | -133.1% |
| March 31, 2022 | -353.8% |
| December 31, 2021 | -133.0% |
| September 30, 2021 | -128.4% |
| June 30, 2021 | -118.1% |
| March 31, 2021 | -97.39% |
| December 31, 2020 | -89.79% |
| September 30, 2020 | -82.70% |
| Date | Value |
|---|---|
| June 30, 2020 | -94.41% |
| March 31, 2020 | 24.61% |
| December 31, 2019 | -428.3% |
| September 30, 2019 | -221.2% |
| June 30, 2019 | -321.3% |
| March 31, 2019 | -47.90% |
| December 31, 2018 | -281.0% |
| September 30, 2018 | -187.3% |
| June 30, 2018 | -63.02% |
| March 31, 2018 | -109.2% |
| December 31, 2017 | 2.29% |
| September 30, 2017 | -42.44% |
| June 30, 2017 | -288.1% |
| March 31, 2017 | -70.86% |
| December 31, 2016 | -223.7% |
| September 30, 2016 | -424.5% |
| June 30, 2016 | -458.2% |
| March 31, 2016 | -721.1% |
| December 31, 2015 | -577.8% |
| September 30, 2015 | -612.2% |
| June 30, 2015 | -284.2% |
| March 31, 2015 | -356.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 20.17% |
| Ocugen, Inc. | -1.25K% |
| Catalyst Pharmaceuticals, Inc. | 42.66% |
| Rigel Pharmaceuticals, Inc. | 14.71% |
| iBio, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -44.05% |
| Return on Assets | -31.34% |
| Return on Invested Capital | -42.30% |
| Gross Profit Margin (Quarterly) | 97.55% |
| Operating Margin (Quarterly) | -191.8% |
| Return on Net Operating Assets | -629.2% |